Home
Therapeutic Categories
- BACK
- Therapeutic Categories
- Allergy & Immunology
  - BACK
  - Allergy & Immunology
  - Chronic Spontaneous Urticaria
  - Food Allergies
  - Pediatric Food Allergies
  - Search for:
- Dermatology
  - BACK
  - Dermatology
  - Plaque Psoriasis
  - Search for:
- Endocrinology
  - BACK
  - Endocrinology
  - Type 2 Diabetes
  - Search for:
- Hematology
  - BACK
  - Hematology
  - Chronic Immune Thrombocytopenia
  - Sickle Cell Disease
  - Search for:
- Hepatology
  - BACK
  - Hepatology
  - Liver Fibrosis
  - Search for:
- Infectious Diseases
  - BACK
  - Infectious Diseases
  - Adolescent Vaccinations
  - Adult Vaccinations
  - Influenza
  - Search for:
- Nephrology
  - BACK
  - Nephrology
  - IgAN & C3G
  - Search for:
- Neurology
  - BACK
  - Neurology
  - Alzheimer's Disease
  - Epilepsy
  - Insomnia
  - Migraine
  - Multiple Sclerosis
  - Tuberous Sclerosis Complex
  - Search for:
- Oncology
- Ophthalmology
  - BACK
  - Ophthalmology
  - Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
  - Search for:
- Osteoporosis
  - BACK
  - Osteoporosis
  - Osteoporosis
  - Search for:
- Psychiatry
  - BACK
  - Psychiatry
  - Major Depressive Disorder
  - Schizophrenia
  - Tardive Dyskinesia
  - Search for:
- Pulmonology
  - BACK
  - Pulmonology
  - Interstitial Lung Disease
  - Search for:
- Rheumatology
  - BACK
  - Rheumatology
  - Rheumatoid Arthritis
  - Systemic Lupus Erythematosus
  - Search for:
- Search for:
Conference Reporter
Conference Calendar
Expert Directory
About Expert Perspectives
Login/Register
Search for:

Oncology

Myelofibrosis

Advertisment

Disease Progression, Symptoms, and Patient Outcomes in Myelofibrosis

Disease Progression, Symptoms, and Patient Outcomes in Myelofibrosis

expert roundtables
By John Mascarenhas, MD; Raajit K. Rampal, MD, PhD; Michael Savona, MD

Evaluating Patient Risk Factors When Diagnosing Myelofibrosis

Evaluating Patient Risk Factors When Diagnosing Myelofibrosis

patient care perspectives
By Michael Savona, MD

Clinical Challenges and Quality of Life in Patients With Myelofibrosis

Clinical Challenges and Quality of Life in Patients With Myelofibrosis

patient care perspectives
By Michael Savona, MD

Individualizing Treatment for Patients With Myelofibrosis

Individualizing Treatment for Patients With Myelofibrosis

clinical topic updates
By Michael Savona, MD

Considering Cytopenias in the Management of Myelofibrosis

Considering Cytopenias in the Management of Myelofibrosis

patient care perspectives
By Raajit K. Rampal, MD, PhD

Load More

Experts in Myelofibrosis

+0

Meet the Experts

Advertisment

2024 Expert Perspectives®

Privacy Policy Terms of Service About Expert Perspectives

Your California Privacy Rights Do Not Sell My Personal Information

Login Expert Perspectives

Forgot Password?

or Create an Account

Create an Account

By submitting a new user registration you’re agreeing to the Privacy Policy and Terms of Service for Expert Perspectives in Medicine and its subsidiaries.